News

A Phase 1 clinical trial testing the experimental therapy KLN-1010 in people with relapsed or refractory multiple myeloma has begun treating patients in the…

The U.S. Food and Drug Administration (FDA) has approved a new combination therapy — Inqovi (decitabine and cedazuridine) plus Venclexta (venetoclax) — to treat adults…

The U.S. Food and Drug Administration (FDA) has given Actuate Therapeutics the green light to begin a clinical trial testing an oral formulation of…

In an early clinical trial testing the novel therapy Alpha DaRT for recurrent glioblastoma, the first three patients given the radiation treatment all showed a…

Liraltagene autoleucel (lira-cel), an experimental cell therapy in clinical development for recurrent ovarian cancer, has been tolerated well so far in an early clinical trial,…

Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib in people with hard-to-treat…

A new genetic test for a group of blood cancers known as myeloid malignancies is expected to soon be available to certain people in…

An artificial intelligence (AI) tool can detect early-stage pancreatic cancer on standard medical scans up to three years before a clinical diagnosis, according to…

The first participant has been dosed in a clinical trial testing the experimental therapy GLIX1 in people with recurrent or progressive glioblastoma, an aggressive form…

May 8 is World Ovarian Cancer Day, a time when advocates around the world raise their voices to increase awareness, support those affected, and…